Fifteen-year treatment of metastatic thyroid medullary carcinoma: a case report
Journal: The European Research Journal (Vol.1, No. 3)Publication Date: 2015-11-04
Authors : Ozen Oz Gul; Soner Cander; Pinar Sisman; Erdinc Erturk; Canan Ersoy;
Page : 160-164
Keywords : Medullary tyroid carcinoma; metastatic; chemotherapy; thyroid cancer;
Abstract
Although very rare, medullary thyroid carcinoma (MTC) is the most aggressive in differentiated thyroid malignancies. We report a 48-year-old male patient with the diagnosis of MTC, who was monitored for fifteen years and showed no serious adverse events due to long-term chemotherapy. Total thyroidectomy, neck dissection, retrosternal nodule excision and pericardiectomy were performed, and radiotherapy was applied to the neck area. Due to progressive metastatic disease cyclophosphamide, dacarbazine, and vincristine were administrated. He tolerated chemotherapy well, and no severe systemic side effects were detected. He died due to multi-organ failure after fifteen years of diagnosis. The only curative treatment is surgery in MTC, however; radiotherapy, chemotherapy, and embolization may be used for patients for whom surgery cannot be performed. Although success rates of systemic chemotherapy are low, it is a treatment option in the progressive metastatic disease.
Other Latest Articles
- Spontaneous ejaculation; caused by venlafaxine, reverted by mirtazapine
- West syndrome and autism: a case report
- Conglutinatio cervicis uteri orifici externi: a rare disorder of uterine cervix
- Tissue eosinophilia: a histopathological marker associated with stromal invasion but not histopathological grade in cutaneous squamous neoplasia
- Surgical removal of an embolized Amplatzer septal occluder device from the right ventricle
Last modified: 2015-11-05 00:47:09